Newly released court files detail Epstein's involvement with key Bitcoin figures, investment discussions, and his role in funding pivotal infrastructure projects during the industry's nascency.
Marketing automation firm Klaviyo is deepening its AI capabilities with a new ChatGPT app and a Wunderkind partnership. Yet, despite these strategic moves, its stock performance tells a more cautious story, leaving investors to weigh its growth potential against a significant valuation discount.
Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.
DoorDash is deploying autonomous delivery robots in the suburbs while advocating for legislation to improve food access for rural seniors, signaling a strategic push beyond its urban core into new markets and use cases.
The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.
First American Financial Corp. announces the retirement of director Martha Wyrsch while reaffirming its quarterly dividend, signaling stability in shareholder returns during a period of governance change. The company's stock performance and capital allocation strategy remain in focus for investors.
Investment firm Tanager Wealth Management has fully divested its position in Centessa Pharmaceuticals, capitalizing on the biotech's near-60% annual surge. The move highlights strategic portfolio rebalancing as the stock's rally potentially amplified its risk profile within a diversified fund.
An analysis of wealth accumulation among the world's top billionaires reveals staggering gains during the current presidential term, with policy and market dynamics fueling unprecedented fortunes.
Amid a steep 60% annual share price decline, investment firm Chicago Capital has significantly reduced its position in PROCEPT BioRobotics, a developer of robotic systems for urological surgery, signaling a portfolio risk reassessment.
Meta CEO Mark Zuckerberg's forecast of a major AI infrastructure build-out through 2026 suggests continued robust spending on Nvidia's hardware, reinforcing the chipmaker's central role in the ongoing tech boom.
Alm. Brand A/S posts robust Q4 2025 results, with net income soaring to DKK 337 million and proposing a record dividend. While underlining its shareholder return strategy, the market grapples with valuation concerns and execution risks in a softening share price environment.
Danaher Corporation announces a strategic investment in Automata, aiming to integrate AI-ready automation systems with its extensive portfolio of instruments and reagents. The move signals a push to deliver comprehensive, data-driven lab solutions as the life sciences sector increasingly prioritizes efficiency and scalability.
Zoom Video Communications' early investment in AI powerhouse Anthropic is emerging as a critical, and potentially undervalued, component of its growth story, prompting analysts and investors to reassess the company's long-term trajectory beyond video conferencing.
Tilray Brands deepens its commitment to Europe's regulated medical cannabis sector with the launch of Tilray Medical Italia, a strategic venture with local partner Molteni Farmaceutici. The move comes as the company seeks to stabilize its growth narrative amid significant stock market volatility.
Shares of Applied Optoelectronics (AAOI) soared to a record high Friday, driven by analyst optimism over its critical role in powering AI data centers with advanced laser technology.
Shares of Colgate-Palmolive jumped over 6% as the consumer goods giant outlined a resilient growth plan through 2026, even after reporting a significant profit decline in a tough operating climate.
The healthcare behemoth's robust 2025 results and 2026 guidance signal a landmark year ahead, as it navigates patent expirations and pricing pressures while maintaining its coveted dividend king status.
Franklin Resources, Inc. (NYSE: BEN) saw its shares climb over 5% following a better-than-expected fiscal Q1 2026 report and the unveiling of its AI-powered 'Intelligence Hub', developed in partnership with Microsoft, signaling a push towards operational modernization.
Dentsply Sirona faces mounting pressure as declining sales and poor capital returns challenge its recovery narrative. With shares down sharply over multiple years, investors question management's strategy in a competitive dental market.
SoundHound AI expands its real-world footprint with a nationwide rollout of voice AI at Five Guys and partners with Bridgepointe Technologies to target the enterprise market, signaling a dual-path growth strategy.
